UPDRS motor score improvement of bilateral stimulation was better than that of unilateral stimulation.
统一帕金森病评定量表(UPDRS)运动评分改善率双侧刺激优于单侧刺激。
Before and after treatment with PD Rating Scale (UPDRS) assessment of the efficacy and adverse reactions were recorded.
治疗前后采用PD评定量表(UPDRS)对疗效进行评估，并记录患者不良反应。
The primary outcome was the change from baseline to six months in the off-phase motor score of the Unified PD Rating Scale (UPDRS).
主要结果是看在后期帕金森病统一评定量表（UPDRS），从基线到六个月的离线阶段动量分数的变化。
Conclusion Dingzhen Decoction can slow the ascending trend of UPDRS score in PD patients and delay the development of Parkinson's disease.
本研究中定振汤可以改善帕金森病症状以及具有延缓病程进展的作用。
The primary endpoint was change from baseline in the total score of the Unified Parkinson's Disease Rating Scale (UPDRS) Part III at the final assessment point.
最后评估总根据统一帕金森疾病评定量表（UPDRS）第三部分的总评分中试验主要终末点相对于试验初期有所改变。
Secondary endpoints included changes from baseline in total daily "off" time; total scores of UPDRS Parts I, II, and IV; and Modified Hoehn and Yahr Scale score.
相对于试验初期次要终末点的改变包括每日“药物无作用”时间，UPDRSI，II，IV部分的总评分以及修正的Hoehn和Yahr的量表评分。
Secondary endpoints included changes from baseline in total daily "off" time; total scores of UPDRS Parts I, II, and IV; and Modified Hoehn and Yahr Scale score.
相对于试验初期次要终末点的改变包括每日“药物无作用”时间，UPDRSI，II，IV部分的总评分以及修正的Hoehn和Yahr的量表评分。
应用推荐